癌症疫苗新突破，北大团队Nature发文

Core Viewpoint - The research team from Peking University has proposed a novel "degradable vaccine" strategy to tackle the challenge of cancer immune tolerance, marking a significant advancement in cancer treatment [1] Group 1: Research and Development - The team, led by Chen Peng in collaboration with Xi Jianzhong and Shenzhen Bay Laboratory, has utilized protein-targeted degradation technology to effectively combat tumor cells [1] - The approach involves delivering multifunctional molecules into tumor cells, compelling these previously "invisible" cancer cells to reveal their identities, thus transforming them from "invisible enemies" to "intelligence messengers" [1]